Prospect Radar · 2026-10-10
AM edition
Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.
NURS.V — via @JonahLupton↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Discloses fund positions and gives a detailed bullish growth and valuation thesis.
- receipt: tweet ↗
BLDR — via @FroehlichThors1↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run -6.0% · no listed options
- thesis: Bearish head-and-shoulders thesis sees a possible decline from $53 toward the $9 COVID low before a future buying point.
- receipt: tweet ↗
PINK — via @LOGOinvestor↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Explicitly recommends PINK as a core healthcare ETF at an attractive price.
- receipt: tweet ↗
PYLD — via @DDBlakeFischer↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Explicitly adds bond exposure and prefers credit funds over duration-heavy Treasury ETFs.
- receipt: tweet ↗
PACB — via @AtlasShrug1↗ (grade A, hot hand)
- crowd: 2 authors / 2 signals · 5d run +0.0% · no listed options
- thesis: Author discloses DNA and PACB entries, a core biotech holding, and continued avoidance of NUAI.
- receipt: tweet ↗
JBLU — via @junkbondinvest↗ (grade A)
- crowd: 2 authors / 2 signals · 5d run -7.5% · no listed options
- thesis: Reports JetBlue secured notes at a new low with 19% yield-to-worst and 1408-bp spread-to-worst.
- receipt: tweet ↗
RBRK — via @MF_Camillus↗ (grade A, hot hand)
- crowd: 4 authors / 4 signals · 5d run +5.5% · no listed options
- thesis: Plans major software reductions on extreme valuations while explicitly keeping PLTR.
- receipt: tweet ↗
6190.TWO — via @Minnvestor↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Presents copper and switching workarounds as potential beneficiaries of constrained optical supply.
- receipt: tweet ↗
PSI — via @VolumeLeaders↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Large prints historically preceded semiconductor pauses or reversals; another occurred this week.
- receipt: tweet ↗
3665.TW — via @Minnvestor↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Presents copper and switching workarounds as potential beneficiaries of constrained optical supply.
- receipt: tweet ↗
PDSB — via @PrismDM↗ (grade A)
- crowd: 3 authors / 3 signals · 5d run +0.0% · no listed options
- thesis: Reports quantified intraday moves across named medtech and fintech stocks.
- receipt: tweet ↗
DNA — via @AtlasShrug1↗ (grade A, hot hand)
- crowd: 5 authors / 7 signals · 5d run +0.0% · no listed options
- thesis: Author discloses DNA and PACB entries, a core biotech holding, and continued avoidance of NUAI.
- receipt: tweet ↗
PM edition
Research candidates, NOT trade signals. Configuration: quiet name + first substantive touch by a graded author + no mechanics poison. Base rate: such touches precede a ±10% move ~1.5× more often than chance — direction unknown. These are names worth YOUR research today.
BLDR — via @FroehlichThors1↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run -6.0% · no listed options
- thesis: Bearish head-and-shoulders thesis sees a possible decline from $53 toward the $9 COVID low before a future buying point.
- receipt: tweet ↗
VTI — via @qualityequities↗ (grade A)
- crowd: 3 authors / 3 signals · 5d run +1.0% · no listed options
- thesis: Explicitly recommends buying and holding broad or paired ETFs for most retail investors.
- receipt: tweet ↗
NURS.V — via @MarkosAAIG↗ (grade A, hot hand)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Discloses a small holding and outlines Hydreight's infrastructure and scaling thesis.
- receipt: tweet ↗
NURS.NE — via @MarkosAAIG↗ (grade A, hot hand)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Discloses a small holding and outlines Hydreight's infrastructure and scaling thesis.
- receipt: tweet ↗
KLAC — via @SKundojjala↗ (grade A, hot hand)
- crowd: 2 authors / 2 signals · 5d run -5.5% · no listed options
- thesis: Maps SpaceX's planned fab spending to semiconductor-equipment beneficiaries, especially KLA.
- receipt: tweet ↗
SCHG — via @qualityequities↗ (grade A)
- crowd: 2 authors / 2 signals · 5d run +1.1% · no listed options
- thesis: Explicitly recommends buying and holding broad or paired ETFs for most retail investors.
- receipt: tweet ↗
RXRX — via @harry03994688↗ (grade A, hot hand)
- crowd: 2 authors / 2 signals · 5d run +5.8% · no listed options
- thesis: Presents AI-enabled biotech as a structural turnaround and highlights high-short-interest names benefiting from squeezes.
- receipt: tweet ↗
IOVA — via @bioinvestor24↗ (grade A, hot hand)
- crowd: 1 authors / 1 signals · 5d run +2.8% · no listed options
- thesis: Notes falling IOVA short interest and argues its resilience forced short covering.
- receipt: tweet ↗
AMAT — via @SKundojjala↗ (grade A, hot hand)
- crowd: 2 authors / 3 signals · 5d run -6.1% · no listed options
- thesis: Maps SpaceX's planned fab spending to semiconductor-equipment beneficiaries, especially KLA.
- receipt: tweet ↗
9984 — via @ALEXEIMARTOV↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Detailed portfolio update discloses long and short books, performance, trades and investment theses.
- receipt: tweet ↗
6584.TW — via @Minnvestor↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Examines King Slide's sales drop, Nan Juen competition and long-term rack-design disruption risk.
- receipt: tweet ↗
2059.TW — via @Minnvestor↗ (grade A)
- crowd: 1 authors / 1 signals · 5d run +0.0% · no listed options
- thesis: Examines King Slide's sales drop, Nan Juen competition and long-term rack-design disruption risk.
- receipt: tweet ↗